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Abstract 
Background: Cervical cancer is reportedly the easiest gynecologic cancer to prevent, and 
measures that have the most impact are regular screening and timely follow-up. Although 
the Papanicolaou (Pap) test used to screen for cervical cancer has been recognized as one 
of the most valuable clinical preventive service for women, variation in screening and 
tracking remain a barrier for some women achieving optimal health. Missed opportunities 
for care in the form of inadequate follow-up is a patient safety and quality of care issue 
that can be appropriately addressed through implementation of a tool to be used as a 
component of a cervical cancer surveillance program. 
Purpose: The purpose of this quality improvement (QI) project was to develop an 
evidence-based, tracking tool for cervical cytology screening to facilitate surveillance 
measures in a community health center. 
Theoretical Framework: The theoretical framework applied was Donebedian’s quality 
of care framework that incorporates the Structure-Process-Outcome model.  
Methods: The study was conducted in five phases over a period of 14 months. After 
permission was granted to implement the study, the tracking tool was developed with 
input from the mentor. The final two phases consisted of training, implementation, and 
evaluation of tool’s effectiveness towards improving practice. A survey questionnaire 
measuring the staff’s opinion of the tool was administered and verbal feedback regarding 
perception of the tool’s capability to impact clinical practice was collected. 
Results: Informal surveys were performed by asking stakeholders to share their attitudes 
and opinions of the surveillance tool. 
  
vi 
 
Conclusion: Consistent evidence-based practice among those charged with providing 
care is paramount to helping patients achieve their best outcome. Surveillance is an 
internal process and improving surveillance is pivotal to the goal of optimizing outcomes. 
The findings of the QI project indicate that through the provision of this evidence-based 
practice, clinical resource, quality of care will be improved. Additionally, the surveillance 
tool will be incorporated into clinical practice and used as the official method for tracking 
abnormal cervical cancer screenings, scheduling follow up care, and tracking patients 
until resolution of cervical pathology. 
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Chapter 1 
 Nature of Project and Problem Identification  
The Centers for Disease Control and Prevention (CDC, 2014b) reported that 
cervical cancer is the most straightforward gynecologic cancer to prevent, and prevention 
can be achieved through regular screening and timely follow-up. The human 
papillomavirus (HPV) is the most common precursor to cervical cancer, and the infection 
rate can be lowered through use of barrier methods during sexual contact and HPV 
vaccine (Centers for Disease Control and Prevention [CDC], 2015a). Cervical cancer is 
treatable and when detected at an early stage women who develop invasive cervical 
cancer have a 5-year survival rate of 91% (American Cancer Society [ACS], 2015).  
Even though evidence and statistics indicate that cervical cancer is highly 
preventable and treatable, this disease continues to be widespread. Statistical summaries 
from the National Cancer Institute (NCI, 2012) reported that in the United States alone, in 
2012 more than 249,000 women were living with cervical cancer. The most recent 
projection for 2015 was 12,900 new cases of cervical cancer and approximately 4,100 
deaths as a result of this malignancy (NCI, 2015).  
   Despite the substantial research that has resulted in the development of national 
recommendations for preventive screening, cervical cancer screening rates continue to be 
insufficient. Screening has been identified as one of the most valuable underutilized 
clinical preventive services for this population (U.S. Preventive Services Task Force
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[USPSTF], 2014). Through the National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP), the Centers for Disease Control and Prevention (CDC, 2016b) 
offered access to screening for low-income, uninsured, and underinsured women. 
However, data for 2010-2012 indicated that greater than 33% of those eligible were not 
screened (Tangka et al., 2015).  
Reasons for low screening rates varied by state and demographics, but the 
constant was that screening rates remained low. Healthy People 2020 (2016a)included 
cervical cancer screening in the objectives and announced a target of 93% cervical cancer 
screening success rate for women ages 21-65 years of age. Although STIs, including 
HPV, are largely preventable, they remain a major health concern in the United States. In 
February 2015, the CDC (2015b) confirmed that nearly 79 million Americans were 
positive for HPV, with 14 million new HPV infections diagnosed annually. 
Problem Statement 
 The problem is that variances in cervical cancer screening practices exist among 
healthcare providers and lack of adherence to clinical recommendations for screening 
decrease opportunities for early detection and treatment for women. 
Purpose Statement 
 The purpose of this quality improvement (QI) project is to develop and implement 
an updated tracking tool for cervical cytology screening to facilitate surveillance 
measures in a community health center.  
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Project Objectives 
Five objectives were formulated for this clinical project: 
1. Address the gap in practice through application of an in-depth literature 
review to identify needs and deficiencies. 
2.  Promote use of nationally recognized clinical practice recommendations 
when screening and making treatment decisions by establishing relationships 
with facility stakeholders, implementing a project that will enhance the 
organization, and obtain their support for project and Institutional Review 
Board (IRB) approval. 
3. Develop a protocol for screening and institute electronic clinical reminder for 
the electronic medical record (EMR) to facilitate screening practices and 
documentation. 
4. Provide training on protocol and additions to EMR.  
5. Evaluate provider utilization and satisfaction with the protocol. 
Theoretical Framework 
 With recognition of the significance of the potential complications young women 
face as a result of delayed care for HPV infection, the theoretical framework applicable 
and relevant to this problem is Donabedian’s (1969, 1988, 1996) quality of care 
framework. This framework provides a system for examining available health services 
and evaluating the quality of care provided (Donabedian 1969, 1988). According to 
Donabedian (1969), the approach to evaluating quality of care can be categorized into 
three compartments: structure, process, and outcomes.  
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Structure-Process-Outcome Model 
These three components are now known as the Structure-Process-Outcome (SPO) 
model. The framework then distinguishes the three components in terms of what 
Donabedian (1969, 1988) considered as the primary factors of each that comprise the 
model. The facility, equipment, personnel, and finances are associated with structure; 
provision of healthcare is the process; and outcome is defined as the achieved result with 
regard to patient health status (Donabedian, 1969). Donabedian’s quality of care 
framework was applied to this clinical project utilizing the SPO model to implement a 
program designed to improve quality of care with application to a cervical cancer 
surveillance program. 
Application of Theory 
 Gardner, Gardner, and O’Connell (2013) used the Donabedian framework to 
examine quality of nursing services. The study focused on care provided by nurse 
practitioners (NP) and the impact of innovative measures on the quality of care they 
provided. Gardner et al. (2013) applied the Donabedian SPO model and considered 
structure as the setting, process as the clinical service provided, and outcome as 
correlated to patient outcome that resulted from the NP involvement in patient care. 
Assessment criteria used for the Gardner et al. (2013) study were applied to three areas: 
(a) knowledge, skills, and performance of providers; (b) communication and teamwork; 
and (c) quality and safety of care provided.  
With application to the present study, within the construct of the three criteria for 
SPO, key assessments reviewed that are also critical to improving the quality of care for 
cervical cancer surveillance are clinical decision making, appropriateness of 
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interventions, patient involvement, and evidence-based practice (EBP) to set the standard 
for care delivery (Gardner et al., 2013). Evaluation for quality of care improvement is 
ongoing. The assumption is that improvement in the process will lead to improvement in 
quality of care. The desired end result is high quality EBP that narrows the gap between 
research and practice. 
Significance of the Project 
Sexually transmitted infections such as the human papillomavirus are generally 
preventable yet remain the most common STI in the United States (CDC, 2015b). The 
CDC (2015) update reported 79 million persons in the United States were HPV positive 
and approximately 14 million new infections occur annually. HPV is so common that it is 
estimated that the majority of people who engage in sexual activity will acquire the 
infection (CDC, 2015b). In addition to the millions who will become infected, the CDC 
reported that cervical cancer will develop in more than 11,000 women as a result of this 
infection (CDC, 2015). In 2012, the ACS estimated there would be 12,170 new cases of 
cervical cancer and 4,220 deaths (Siegel, Naishadham, & Jemal, 2012). The ACS 
statistical projections concurred with those of the NCI for 2015, with an estimate of 
12,900 newly diagnosed cases of invasive cervical cancer. Of these, 15% will be in 
women over the age of 65 and result in 4,100 cervical cancer-related deaths. 
Although a marked decline is well documented in the number of cervical 
dysplasia reports that have progressed to cervical cancer since the introduction of the 
Papanicolaou (Pap) test, many women are not being screened or are screened 
inappropriately. The American College of Obstetricians and Gynecologists ([ACOG], 
2012a) reported 60% of cervical cancers are discovered in women who were inadequately 
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screened. The statistical evidence cited previously signifies the importance of cervical 
cancer screening and surveillance to identify abnormalities and intervention to prevent 
progression to cancer. In efforts to combat this health disparity and mitigate potential 
long-term complications, several professional affiliations and expert panels have 
provided evidence-based clinical recommendations to support providers during their care 
of this population.  
Currently, as summarized in Table 1, the U.S. Preventive Services Task Force, 
American College of Obstetricians and Gynecologists, American Cancer Society, 
American Society for Colposcopy and Cervical Pathology (ASCCP), and American 
Society for Clinical Pathology (ASCP) concur on the criteria and methodology for 
cervical cancer screening for average-risk women (Centers for Disease Prevention and 
Control {CDC], 2012; Saslow et al., 2012; USPSTF, 2014). However, these clinical 
recommendations are not incorporated into the routine practices of many primary care 
providers. Therefore, opportunities for screening, prevention, and treatment are missed. 
One major barrier to following clinical recommendations is confusion due to the 
recent changes that led to difficulty interpreting guidelines to incorporate them into 
practice (Schwaiger, Aruda, LaCoursiere, Lynch, & Rubin, 2013). In addition to 
adherence to clinical recommendations for screening, the functionality of surveillance 
programs may be an added barrier. Dupuis et al. (2010) noted that it is not enough to 
simply screen for cervical cancer but to recognize that the successes of screening tests are 
predicted by the percentages of follow-up for abnormal findings. Dupuis et al. (2010) 
stated if appropriate intervention does not occur for abnormal results, then the 
opportunity for prevention is missed, yielding the Pap test ineffective. 
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Table 1  
Summary of Cervical Cancer Screening Clinical Recommendations 
 
2012 
Update 
Cervical 
CA 
Screening 
 
 
 
 
 
Initiate 
Screening 
 
 
Screening 
Intervals w/ 
Cytology 
Alone 
 
 
 
Screening Intervals  
Cotesting 
Cytology + HPV 
 
 
 
 
 
Discontinue Screening 
ACS  
ASCCP 
ASCP 
Age 21 21-29 years of 
age; screen 
every 3 years 
30-65 years of age; 
screen every 3 years 
Age 66 and older w/ 
adequate negative history, 
no history of CIN 2, CIN 3, 
or CA within last 20 years 
3 consecutive negative Pap 
or 2 negative cotests within 
last 10 years 
 
USPSTF 
 
Age 21 
 
21-29 years of 
age; screen 
every 3 years 
 
30-65 years of age; 
screen every 3 years 
 
Age 66 and older with 
adequate screening history, 
no other risk for cervical 
CA 
 
ACOG 
 
Age 21 
 
21-29 years of 
age; screen 
every 3 years 
 
30-65 years of age;  
screen every 3 years 
 
Age 66 years and older 
with adequate prior 
negative history, no history 
of CIN 2, CIN 3, or CA 
 
 
Note. CA = Cancer; ACS = American Cancer Society, ASCCP = American Society for 
Colposcopy and Cervical Pathology, ASCP = American Society for Clinical Pathology, 
USPSTF = U.S. Preventive Services Task Force; ACOG = American College of 
Obstetricians and Gynecologists.  
 
Recommendations applicable to women with average risk of developing cervical cancer. 
Adapted from ACS, USPSTF, and ACOG recommendations for cervical cancer screening 
(CDC, 2012). The information provided is a general overview of guidelines. An in-depth 
detail of guidelines is available through any of the above organizations.  
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Missed Opportunities to Screen 
Healthcare providers in various settings are given an opportunity to provide 
medical management and advocate for health promoting behavior for patients who are at 
risk for exposure to HPV. Healthy People 2020 (2016a) chose cancer as one of its leading 
health indicators, and identified a cervical cancer screening target of 93%. However, 
most cervical cancers occur in women who have gone without screening for more than 
five years and this rate may be as high as 25% for those without health insurance or 
primary care providers (CDC, 2014). The Centers for Disease Control and Prevention 
(CDC) recognize this health disparity, and currently has a long-standing commitment to 
providing cervical cancer screening services to low-income, uninsured women through 
the NBCCEDP. In the past 5 years (2006-2011) of the program, the NBCCEDP has 
screened over 1.1 million women for cervical cancer. However, estimates show that 
between 2004 and 2006 the NBCCEDP was able to provide Pap tests to only 9% of 
program eligible women. During this same period, it was estimated that nearly 35% of 
women eligible for the NBCCEDP did not receive cervical cancer screening from any 
source (CDC, 2016b; Smith, Wilson, Orians, & Byrd, 2013). 
An additional factor contributing to missed opportunities to screen is inefficient 
surveillance programs. Many healthcare facilities use claims data for tracking for lack of 
a better method. This tracking method may be sufficient for the insured population, but 
for centers serving the uninsured, claims data do not capture this population. According 
to Nadpara, Madhavan, Khana, Smith, and Miller (2012) in their study of population 
health management, claims data as a surveillance method for cervical cancer screening 
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rates did not meet the goals set by Healthy People 2010 and hence had little impact on the 
disparities in incidence and mortality for this demographic. 
Significance of Cervical Cancer Surveillance  
Cervical cancer surveillance may be accomplished with a manual or electronic 
tool or tracking system. The method of surveillance may be important for sustainability 
but not as critical as the process itself. Regardless of the system used, the key is to 
provide accurate and timely follow-up for patient care and appropriate and correct 
information for the provision of care. Failure to provide timely preventive care, 
appropriate follow-up, and necessary treatment can have detrimental effects on patient 
outcomes and healthcare costs (Benard et al., 2012). The American College of 
Obstetricians and Gynecologists (ACOG, 2012b) recommended tracking begin at the 
initial visit with good communication between patient and provider regarding test and 
potential follow-up. As additional support for surveillance, ACOG (2012b) cited tracking 
systems as an effective tool to enhance the safety and quality of care, increase screening 
compliance, and decrease adverse patient outcomes due to delayed diagnosis and 
treatment.  
In response to the significance and the seriousness of this health problem and the 
evidence reported, this capstone project identified and implemented strategies to be used 
in the primary care setting. The QI project was designed to develop a surveillance 
tracking tool to facilitate early detection and timely follow-up of women at risk for 
cervical cancer.  
The target population for this project was staff who provided, coordinated, and 
assisted with care of women who received cervical cancer screening at a community 
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health center. Project participants were healthcare providers at the center who supplied 
care. The project incorporated current evident-based clinical recommendations and 
updated cervical cancer screening guidelines to support screening and surveillance for 
young women within this demographic.  
Two measurable objectives to determine impact of study were the percentage of 
age-appropriate women screened for cervical cancer and time from results to follow-up 
care before and after implementation. These objectives were not feasible for this project 
because of the limited time frame of project. Later long-term study will provide the most 
meaningful results but may be skewed due to the transient population, such as college 
students and changes in economic status that alter insurance affordability.  
In efforts to facilitate a standardized approach in the clinical setting, I proposed 
the use of a standardized surveillance and documentation tool that may be incorporated 
into the electronic medical record (EMR). However, the EMR could not be modified to 
accommodate the tool, therefore it was made available as an excel spreadsheet. The 
spreadsheet was then uploaded to a shared drive and made accessible to designated 
women’s health staff to have read and edit privileges. Although an accessible tool within 
the EMR is ideal, a replicable product may also be a valuable instrument that will allow 
for continued updates to sustain currency with changes in standards of care. The 
implementation of this program required interdisciplinary coordination with the public 
health, information technology, and facility support staff and other healthcare providers.  
Significance to Nursing Practice and Health Outcomes 
 The introduction of what is now described as high quality screening, in which 
liquid based cytology and HPV co-testing for women are utilized as indicated, has led to 
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a marked decline in mortality and an unprecedented 5-year survival rate of 92% (Saslow 
et al., 2012). This percentage is strong evidence that cervical cancer surveillance plays a 
vital role in improved health outcomes. Not only were patient screening rates increased 
but also timely follow-up and treatment were provided; screening alone has been shown 
to be less than optimal (Saslow et al., 2012). To ensure a similar positive impact within 
the community health center, the current cervical cancer surveillance program was 
modified to improve effectiveness and efficiency, and relevant staff were educated on 
application of tool. The American Association of Colleges of Nursing (AACN, 2006) in 
The Essentials of Doctoral Education for Advanced Nursing Practice outlined the 
responsibility of doctorally prepared, advanced practice registered nurses (APRN) on 
their roles in advancing practice and improving patient outcomes. The healthcare 
challenge of the high rate of HPV infection in women offers an opportunity to implement 
plans that have the promise to affect positive change in practice and outcome.  
Nursing Practice   
 Although cervical cancer is preventable and may be a common reason to seek 
healthcare, the illness places a certain economic burden on society. Esselen and Feldman 
(2013) reported cervical cancer screening and treatment of HPV-related diseases in the 
United States was estimated to cost 4.6 billion dollars. Delayed diagnosis is often 
implicated as a factor in the rising costs of healthcare. Esselen and Feldman (2013) 
studied the cost effectiveness of cervical cancer prevention and reported a credible 
measurement of health outcomes in evaluation of life-years saved and quality of life for 
survivors. Understanding the implications on health and health outcomes regarding 
cervical cancer related disease, the impact for nursing practice at the community health 
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center was to exercise due diligence in the role of preventive care. Nursing practice at the 
community health center accepted the role and worked collaboratively to implement a 
tool to positively promote cervical cancer surveillance within their facility.  
In the current clinical project, the aim was to develop a surveillance tracking tool 
to facilitate early detection and timely follow-up of women at risk for cervical cancer. To 
achieve these results, a multifaceted surveillance product was introduced that combines 
clinical knowledge, strategies tailored to improve tracking, and ongoing evaluation to 
increase adherence to use of the tracking program. Beyond the scope of this project, 
continued evaluation is nevertheless imperative to successful implementation of a 
continuous process improvement initiative. Accordingly, to achieve the desired outcome, 
implementation of clinical guidelines in a specific clinical site may require adjustment to 
meet the needs of that particular setting (Schwaiger et al., 2013). 
The project’s significance to nursing practice constitute the implications for future 
nursing research, evidence-based practice, and quality improvement. Nursing research is 
important to generate new knowledge regarding cervical cancer surveillance. The 
incorporation of evidence-based practice in clinical decision making promotes use of the 
latest clinical information and encourages data search for best practice. Finally, in effort 
to answer the clinical question, a spirit of inquiry is cultivated among nurses to develop 
and implement quality improvement initiatives. According to Mick (2015) clinical 
projects that apply evidence-based practice as a process have an increased chance of a 
seamless transition to quality improvement, and less of a leap from research question to 
research methodology. 
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After my review of the current literature, discussed in Chapter 2, the need is clear 
for practice alignment that will achieve the best patient outcome. Tools to facilitate the 
project are not limited to but include educating providers and staff regarding clinical 
guidelines, maximizing accessibility of standardized screening recommendations to 
minimize missed opportunities, and prompts within EMR as permitted. Further, the 
conducting of periodic analyses of adherence to recommendations is essential through 
assessment of the surveillance tool.  
Healthcare Outcomes 
 Following program implementation is assessment. Relative to a desired increase 
in age-appropriate cervical cancer screening, effectiveness may be measured by an 
increase in ratio of number of patients screened to the number of patient encounters. 
These findings require long-term follow-up and may not be available during my clinical 
project time frame. Thus, other measures of process improvement effectiveness were 
considered and reported. Education was a critical factor that helped determine the success 
of the project. An organization equipped with tools to educate their population will not 
only enhance patient care but also patient outcomes.  
 Implementing interventions designed to improve practice is a QI initiative and 
should be welcomed. However, challenging providers’ autonomy and altering established 
practice routines may be seen as upsetting and met with resistance. A known and 
effective means of affecting change is to involve staff in the decision making process 
(Kettinger, 2013). It is also critical that those involved understand the cause, as well as 
the desired end result. The goal is improving cervical cancer surveillance to improve 
health outcomes.  
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ACOG (2012b) updated its committee opinion also to reflect the need for accurate 
and effective tracking to improve quality of care that results from prompt diagnosis and 
early treatment. Overall success of the project was interpreted as improved healthcare 
outcomes through its impact on number of patients screened, which translates into 
increased detection, timely treatment, fewer complications, and dollars saved. The 
patient’s role in prevention, detection, and treatment is critical, but it is an external factor. 
Screening and surveillance are internal factors that may be controlled by healthcare staff 
and are important steps toward affecting noticeable change in preventing and treating this 
disease.  
 Finally, the strategies and interventions discussed are capable of making a 
difference. Working to establish change in the healthcare setting is pivotal but may be 
minimally effective if applied independent of patient-related involvement. Promoting a 
culture of enhanced compliance with clinical recommendations, however, may be the 
necessary beginning. Implementing a plan with action is the desired goal, and this 
project, designed to improve surveillance, requires the action of implementation. 
Significance of Healthcare Delivery and Policy 
 Healthcare delivery, governance, and health demands with increasing complexity 
have changed over the years, and the nursing profession has evolved to meet those 
demands. The demand for safe, quality, patient-centered, and cost efficient healthcare has 
led to the call for nurses to fill the gap (Institute of Medicine [IOM], 2011). 
Consequently, the demand for cost efficient care without sacrifice of quality has also 
increased the demand for the APRN to deliver excellent patient care. The IOM (2011) 
The Future of Nursing report recognized that nurses are leaders in healthcare and are 
15 
 
 
 
pivotal contributors to the transformation of the healthcare system. Transformation 
includes the universality of access to healthcare, cost containment of care, and 
prevention. In the future of nursing, these aspects will be a major focus that directly 
impacts access and cost (Golden, 2015). 
 Healthcare delivery. Nurses continue to be leaders in healthcare and are believed 
to be key players in the nation’s goal to deliver high quality care. Buppert (2015) 
concurred that nurses, particularly the APRN, are the new faces of medicine. The nursing 
profession for too long has been overlooked and underutilized in medical practice, have 
worked long and hard to claim their rightful place, and now the challenge is to maximize 
this opportunity. 
Advocating for EBP, providing quality care, and continually striving to practice at 
the highest capacity are only several of the ways that nurses affect care delivery. 
Specifically, the application and promotion of EBP has resulted in improved quality and 
safety of healthcare (Eade & Henning, 2013). Eade and Henning (2013) highlighted 
nurses’ roles in EBP in identifying a STI as an important health concern for youth. The 
researchers described a screening tool to enhance the risk assessment for that population, 
in which improved assessments maximized opportunities to treat, educate, and enhance 
outcomes.  
 In the current project, improvement of cervical cancer surveillance at the 
community health center is indicative of the innovation needed in healthcare. Kovner and 
Knickman (2011) discussed healthcare delivery by proposing health systems function 
proactively and encouraging providers to focus on the maintenance of health instead of 
reactions to illness. The plan of study for this clinical improvement project was intended 
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to function in this manner. An efficacious surveillance program included and was led by 
nursing staff, to incorporate provider input, follow facility protocol, and adhere to clinical 
recommendations. 
 Healthcare policy. Another critical and significant role that nursing plays in 
healthcare is policy. Nursing may impact policy from one level to another at the local, 
state, or national levels. Mund (2012) referenced the IOMs report that called for nursing 
to seek leadership roles and participate in policy making that impacts the present and 
future of healthcare. In addition to the 2011 IOM report, the development and 
implementation of the Affordable Care Act is also a driving force behind the impetus for 
APRN to elevate their role in the delivery of healthcare and policy (Mund, 2012). Hence, 
nursing is now preparing the professional nurse who is educated at the Doctor of Nursing 
Practice (DNP) level to design, influence, and implement healthcare policies (AACN, 
2006; Lathrop & Hodnicki, 2014). In response, nurses are working to enact laws and 
change policy. The improvement of clinical practice within an ambulatory patient care 
setting, such as the present research site, may not have an impact on national policy but 
can change policy at the local level.  
 For this capstone project, successful implementation required changes in facility 
protocols and standard of practice within the organization. This outcome is congruent 
with the project goal, to improve upon existing policy that guides screening and to 
institute new directions where needed. The existing facility protocols are scant in detail 
and have not been updated to reflect the current clinical recommendations.  
Changes and updates should revamp the existing protocols that represent the latest 
guidelines supported by ACS (2014), ACOG (2012a, 2012b), and USPSTF (2014) and 
17 
 
 
 
provide a working document to ease accessibility to information without replicating 
available literature. Additionally, references were provided within the protocol to guide 
the search for detail not included in the written protocols. Further, designated review time 
frames of established protocols were suggested the facility leadership to facilitate 
maintenance of currency. The purpose for these changes was local policy impact. 
  Every initiative is not designed to have a global impact but some initiatives 
provide excellent and exceptional guidance to affect change on a smaller scale. With a 
positive local impact, however, there is always the potential for best practices to be 
adopted by other institutions. Hence, this QI project could serve as a model for expansion 
across various health delivery systems. 
Summary 
 The goal of this QI project is implementation of goals into action that may 
improve clinical practice and patient outcomes. The application of the theory of 
Donabedian’s (1969, 1988) quality of care framework aided in the analysis of quality 
through application of Donabedian’s Structure-Process-Outcome model. The significance 
of healthcare practice, outcomes, delivery, and policy were discussed to present a clearer 
view of the importance and possible contribution of this QI initiative to positive health 
outcomes for revamping an organization’s cervical cancer surveillance process.  
A key essential for the Doctor of Nursing Practice student is to collaborate with 
other healthcare professionals to improve patient and population health. The Patient 
Protection and Affordable Care Act is a nationally recognized legislation that stipulate 
nursing as positively affecting healthcare. This legislation is vital to the progress for 
advanced nursing practice and the realization of the vital role of nurses’ in the provision 
18 
 
 
 
of care. According to Osborne (2011) the demand for the APRN has been heard, and 
nurses are poised to meet the demand. The IOM (2010) recommended nurses partner with 
other healthcare professionals, a recommendation already being followed, as nursing care 
is a collaborative effort. 
As an experienced practicing nurse, I believe that nursing will also continue to 
have a presence in healthcare policy. Price (2010) wrote that “policies are introduced 
where a particular sort of change is considered urgent or important enough to prompt 
more concerted adjustments to practice” (p. 41). Nurses are change agents and, from state 
to state, they are working towards change that will make a positive difference in 
healthcare delivery and policy (Osborne, 2011).  
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Chapter 2 
Review of the Literature 
 The human papillomavirus is the most common sexually transmitted infection in 
the United States and the leading cause of cervical cancer (CDC, 2014b). Cervical cancer, 
once the number one cause of cancer- related deaths among women, is now ranked the 
14th leading cause of female cancer- related deaths (CDC, 2014b). In 2012, it was 
estimated that 12,170 cases of invasive cervical cancer would be diagnosed and an 
estimated 4,220 women would die (Siegel et al., 2012). This estimate is despite the CDC 
(2014b) report that cervical cancer is the least problematic gynecologic cancer to prevent. 
Although documented as preventable, HPV-related disease entities continue to plague 
women at various stages in their lives. In an effort to combat risks and incidence of 
cervical cancer, several national organizations collaborated to provide clinical practice 
guidelines and recommendations to direct screening and treatment (Saslow et al., 2012), 
as shown in Table 1.  
 The incidence of the progression to cervical cancer resulting from undiagnosed 
HPV infection has been attributed to several factors. Infrequency of gynecological 
screening is a prime contributor to the incidence of cervical cancer and complications 
resulting from HPV infection (Saslow et al., 2012). Patient education and lack of 
knowledge regarding the implications for undiagnosed and untreated gynecological 
disease and infection are also included in the reasons for disease advancement (Fish et al., 
2013; Slone et al., 2013).  
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Additionally, a factor that is not solely the patient’s responsibility is follow-up for 
routine and abnormal clinical results. The focus on disease prevention instead of 
treatment has shifted some of the responsibility for ensuring that preventive care is 
achieved to the healthcare provider and practice (Healthy People 2020, 2016a, 2016b). A 
critical and necessary component for providing safe, quality, and timely care is the 
utilization of a reliable tracking, patient notification, and reminder system. The purpose 
of this literature review is to examine factors affecting adherence to screening and 
follow-up, review implications for loss to follow-up, and identify the significance of 
effective tracking systems in the provision of safe care. 
Search Methods 
 A review of the literature centering on cervical cancer screening and follow-up 
was completed using electronic searches of studies through Nova Southeastern 
University’s Alvin Sherman Library, Research, and Information Technology Center. 
Searches were by database subject, limited to publications from 2010 to 2016, and were 
conducted in Cumulative Index to Nursing and Allied Health Literature Complete 
(CINAHL) and ProQuest Nursing & Allied Health Science. Additional searches for 
current national statistics and national committee and organization opinions were 
conducted with Google search engine.  
The primary search terms and phrases used in various combinations were the 
following: cervical cancer, cervical cancer screening and tracking, HPV infection among 
females, screening practices, Pap test tracking and follow-up, nursing informatics, 
cervical dysplasia programs, electronic medical record, documentation, Pap 
notifications, abnormal Pap, adherence to follow-up, and clinical practice guidelines for 
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cervical cancer screening. Criteria for the search were that articles in English, full text, 
and in peer-reviewed academic journals. A total of 28 articles were retrieved for this 
review.  
Cervical Cancer Screening 
 The literature review focused on cervical cancer screening, tracking, and follow-
up. In addition to highlighting statistics, prevalence, morbidity, and mortality for cervical 
cancer among women, the evidence confirmed the need for a standardized process for the 
clinical management of normal and abnormal screening results (Calhoun, Goode, & 
Simmons, 2011; Fish et al., 2013; Stone et al., 2013). Although cervical cancer deaths 
have declined significantly over the past 30 years, the disease has nevertheless had a 
major impact on women’s health, with minority women suffering the greatest risk 
(American Cancer Society [ACS], 2014). In the United States, Hispanic women have the 
highest rate of cervical cancer, followed by African-American women (ACS, 2014; 
Centers for Disease Control and Prevention [CDC], 2014d). 
 The review emphasized several factors that are acknowledged to have contributed 
to the decline in cervical cancer-related mortality. The marked decline related, first, to the 
adoption of the Pap test by the ASCCP. More recently, the decline was attributed to the 
inclusion of the HPV test at defined screening intervals (Saslow et al., 2012). 
Adherence to Screening and Follow-Up  
Jalilian and Emdadi (2011) observed that an estimated 500,000 new cases of 
cervical cancer will be diagnosed worldwide each year making cervical cancer the second 
most commonly diagnosed cancer in women. The literature reveals that the high 
incidence of cervical cancer is directly associated with a lack of screening and inadequate 
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follow-up for abnormal findings (results (Calhoun, Goode, & Simmons, 2011; Fish et al., 
2013; Stone et al., 2013). The theme throughout the literature was that adherence to 
clinical guidelines and recommendations for follow-up by both provider and patient was 
key to maximizing patient health and positive outcome.  
Despite the importance of preventive care, the attention to reports of 
inconsistencies between medical records and patient accounts of history prevail; these are 
known gaps in knowledge about HPV and nonadherence to screening recommendations. 
Dupuis et al. (2010) studied innovation and improvement for tracking abnormal cervical 
screening and noted that “screening for cervical cancer with a Pap test is only as 
successful as the follow-up rate for an abnormal result” (p. 575). This is a valuable 
caution and should alert any clinician and patient that the result of the test is just as 
important as the test itself.  
As a professional healthcare provider, I have never adhered to the principle of “no 
news is good news” for those in my care. Rather, I have always impressed upon 
individuals seeking care not to be content until they are informed of the results and have 
received instructions regarding care and recommendations for any necessary follow-up. 
Sepulveda and Young (2013) confirmed this outlook in reporting on methods to improve 
a laboratory information system. The initial goal was to optimize laboratory operations; 
however, it also proved that clinical care could be improved with appropriate and 
meaningful management of laboratory information (Sepulveda & Young, 2013). 
Sepulveda and Young reaffirmed the premise that adequate follow-up for cervical cancer 
screening is paramount to health and well-being. 
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Implications for Loss to Follow-Up 
The disparities in healthcare are well documented, including the incidence and 
mortality associated with cervical cancer. Nadpara et al. (2012) addressed population 
health and noted that even among those with Medicaid provision of full coverage for 
preventive screenings, these individuals’ consistently yielded lower rates for screening. 
Loss to follow-up was also a result of inaccurate patient accounts and insufficient 
medical record documentation of patient history.  
Further, patients’ understanding of the recommendations for follow-up is a 
significant barrier to their receiving the appropriate level of care at the appropriate time 
(Slone et al., 2013). Slone et al. (2013) performed an in-depth review of cervical cancer 
screening programs for 13 health departments in Kentucky, assessing the correlation 
between patient self- reports and health department records for follow-up. The 
discrepancy between patients’ self-reports of what they understood and what the health 
department documented in their medical records as follow-up recommendations was 
53.8% (Slone et al., 2013). Noting the report was limited to a small population, Slone et 
al. nevertheless emphasized that what patients hear or interpret may be far from the 
intended message communicated by the healthcare team.  
Effective Tracking Systems  
 Variances in screening, reporting, and tracking underscore the need to establish 
and maintain systematic protocols to create and sustain reliable methods for 
communication between patients and staff. ACOG (2012b) concluded that the tracking 
process for any patient should begin at the initial visit and continue throughout the care 
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continuum. The foundation for safe and quality care is the accuracy and timeliness of 
communication between the healthcare team and patient (ACOG, 2012b).  
With regard to the importance of an effective tracking system, seven studies and 
one discussion article highlighted the potential negative impact delayed reporting had on 
health outcomes. Anderson, St. Hilaire, and Flinter (2012) suggested that focus be placed 
on prioritizing program goals that may be identified through the process of survey before 
and after implementing changes. Although not specific to women’s health preventive 
screening, Awan, Wagenberg, Daly, Safdar, and Nagy’s (2011) article on tracking delays 
was reviewed and was considered relative because the authors pointed out the potential 
for adverse impact when a tool is relied on without a means of checks and balances. 
Awan et al. (2011) addressed the quality control and assurance that indicated the clinician 
was knowledgeable of the technology and that a gap in knowledge would not be 
problematic for information interpretation. Hence, a reminder that a system of tracking 
provides value but may also present challenges if the proper training for system use does 
not occur. 
 The literature was consistent in recommendations for a preventive care tracking 
system, whether it tracked one screening or several. The variance revealed was in the 
type of program; electronic and manual were both classified as appropriate tracking 
methods. The intent of both methods was to capture the information and develop a 
consistent manner of communication (Dupuis et al., 2010; Calhoun et al., 2011). Fish et 
al. (2013) indicated that in addition to a tracking system, adherence to follow-up was 
improved when coupled with counseling, reminder calls, and written appointment 
notifications. Tracking via the EMR was proposed by Dupuis et al. (2010) and Calhoun et 
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al. (2011) as the premier step to improvement of the process of Pap test tracking. Both 
studies focused on time efficiency and elimination of errors and variance. Systems 
include reminder prompts for staff, standardized templates, and the potential for cross-
system communication with an automated process to capture laboratory and pathology 
reports (Calhoun et al., 2011; Dupuis et al., 2010).  
Summary 
 The evidence is clear that cervical cancer screening and surveillance is a 
necessary and valuable tool for early detection and treatment for HPV-related conditions 
(ACOG, 2012a; Bernard et al., 2012; Saslow et al., 2012; Centers for Disease Control 
and Prevention [CDC], 2014a). Evidence also supports the use of reminders for clinical 
staff and patients to improve compliance with clinical recommendations for preventive 
screenings and follow-up (ACOG, 2012b; Dupuis et al., 2010). Missed opportunities for 
care in the form of inadequate follow-up and nonadherence to clinical practice 
recommendations are patient safety and quality of care issues that should be addressed at 
the local level.  
Many of the variances can be rectified with the enforcement of policies and 
procedures that direct healthcare staff in the expectations for patient care. Policies and 
procedures may include clinical protocols, standardized processes for communication 
flow between clinicians and patients, and the understanding that all office staff should 
follow the defined protocols (ACOG, 2012b). The elements to be tracked are negotiable, 
however data should be made readily available to all associated staff and should be 
consistent in language. 
26 
 
 
 
 As a result of the literature review, additional interventions were suggested as 
well as a postintervention survey (Anderson, St. Hilaire, & Flinter, 2012). Within the 
preintervention survey, critical information for successful revamping of a program is 
identification not only of existing protocols but highlighting of key elements that may be 
missing. Items to look for during the preintervention survey are defined as timely follow-
up guidelines, data collection and tracking methods, patient navigation system, care 
coordination, and the roles of patient care staff (Anderson, St. Hilaire, & Flinter, 2012). 
All of these components assist with establishment of a program that maximizes 
opportunity to effectively track and increase adherence to follow-up care. Defining of 
roles is also essential to enhancing the probability and opportunity for each level of care 
provider to perform to the full extent of their scope of practice, thus, defined roles should 
be outlined in protocols governing cervical cancer surveillance and screening (IOM, 
2010). 
 Finally, the overall goal for evaluating strategies to improve cervical cancer 
surveillance is to promote quality healthcare and optimal health outcomes (Beydoun, 
Dail, Tamim, Ugwu, & Beydoun, 2010). With regard to quality and safety, Healthy 
People 2020 (2016b) identified two goals pertinent to this project: (a) reduction of the 
number of new cancer cases to include morbidity and mortality caused by cervical 
cancer, and (b) implementation of effective strategies to prevent sexually transmitted 
diseases (STDs) and their complications. The evidence shows that with continued focus 
on preventive care, health literacy, and culturally competent  interventions that increase 
cervical cancer screening rates, the result is less barriers to care and a reduction in 
cervical cancer related morbidity and mortality (Nardi, Prabjot, & Selix, 2016).  
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Chapter 3 
Methods 
 Sexually transmitted infections such as the human papillomavirus are largely 
preventable yet HPV remains one of the most common STIs in the United States (CDC, 
2014a) and is the most prevalent precursor for cervical cancer. In response to the 
prevailing statistics and morbidities associated with the HPV infection among women, it 
is imperative that healthcare providers make every effort to screen, diagnose, treat, and 
follow until resolution evidence of HPV to help patients achieve their best outcomes. The 
problem of variances and deficiencies in gynecological preventive health screenings has 
increased the need and urgency for standardization within healthcare organizations. 
Hence, the purpose of this QI project was to develop and implement an updated 
tracking tool for cervical cytology to facilitate surveillance measures in a community 
health center. The proportion of inadequately screened women is higher among older, 
minority women, and minority women suffer the greatest risk and negative impact of 
cervical cancer and HPV infection (ACS, 2014). In the United States, African-American 
women have the second highest rate of cervical cancer, surpassed only by Hispanic 
women (ACS, 2014; CDC, 2014b). The statistics indicate that cervical cancer screening 
continues to be an underutilized tool for early detection and prevention of disease 
(USPSTF, 2014).
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Project Design 
 The aim of this QI project was to address gaps in surveillance of cervical cancer 
screening by implementation of an effective and efficient tracking tool to help mitigate 
variances in clinical practice and discrepancies in care. The project design used the 
Stetler (2001) model of research utilization to facilitate evidence-based practice. The 
2001 version of the Stetler model discussed the steps of research utilization that enhance 
application of evidence-based practice and more specifically detailed the concepts of the 
preparatory and evaluation processes (Stetler, 2001). 
Setting 
 The community health center is an ambulatory healthcare organization that 
provides medical services to residents living in eight rural counties within North Florida. 
The community health center has two locations and a mobile unit, with some variation in 
services available dependent upon the location. Only one location offered gynecological 
care and that center was chosen for project implementation. The facility utilized for this 
project is centrally located on the south side of town, has public transportation in close 
proximity, and offers a range of services to include primary care, obstetrics, gynecology, 
and dental. The project focused on the women’s health department at the selected facility. 
The center affords access to care, regardless of patient ability to pay, a source of pride to 
the organization. Thus, uninsured or underinsured individuals within the community have 
access that might otherwise not be available. 
 The Florida Department of Health (FDOH) compiled statistics for 2011 that 
identified the state as second in the nation for cancer burden; cancer was Florida’s 
leading cause of death (FDOH, 2012; Centers for Disease Control and Prevention [CDC], 
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2014c). Cervical cancer was among the state’s top 10 most commonly diagnosed cancers, 
with 857 new cases and 312 deaths reported in 2010 (NCI, 2012). Additionally, women 
living in rural counties were estimated to have lower screening rates yet they had a 
greater number of cervical cancer detected and more detected at an advanced stage.  
The NCI (2012) reported 67.6% of African American women were diagnosed at 
an advanced stage of cervical cancer, compared to 49.3% of Caucasian women. The 
women who receive care at the community health center are within this population of 
minority, lower socioeconomic status women, and reside in rural areas. Therefore, 
community health center is an ideal location for improvement of the quality of care with 
development of a cervical cancer surveillance tracking tool. This tool should mitigate the 
occurrences of missed opportunities to provide community residents with this valuable 
source of preventive care.  
Participants 
Criteria for Inclusion 
 The improvement project required participation of management and staff in 
various positions. Additionally, guidance for inclusion incorporated the clinical 
recommendations of ACOG, CDC, and USPSTF (Saslow et al., 2012). The major 
criterion for inclusion was employment at the community health center. Personnel were 
included because of their roles in policy development and approval, access to policies, 
procedures, interaction with healthcare providers, interaction with patients, potential 
impact on documentation, records management, routing diagnostic results, and 
information technology specialists.  
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These members were recruited through my solicitation of their support and 
pointing out the opportunity for improvement in quality of patient care. The recruitment 
of identified key stakeholders included efforts that provided information on QI initiative, 
staff education on benefits of program, demonstration of the effectiveness and efficiency 
of use, and appeal to the healthcare providers’ desire to help patients achieve their best 
outcomes. 
Criteria for Exclusion 
 There were two criterion for exclusion. The first criteria was individuals who 
were not employed at the community health center location that performed cervical 
cancer screenings. The second criteria were employees who had no direct patient care 
roles with cervical cancer surveillance. 
Participants’ Roles 
A total of 10 participants were involved in project implementation. The roles of 
each participant are summarized in Table 2. The chief medical officer and information 
technology personnel had key roles in project implementation but were not users of the 
tool and thus did not complete the survey.  
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Table 2 
Roles of Project Participants 
 
 
Staff Assigned Role 
 
Number of Staff 
Members 
 
 
Physician 
 
2 
 
Advanced Registered Nurse Practitioner 2 
 
Registered Nurse 1 
 
Case Manager 1 
 
Medical Assistant 3 
 
Information Technology 1 
 
Total Staff Participated 
 
              10 
 
Ethical Considerations 
 
 Development of this tracking tool did not require contact with patients or access 
to records that disclose protected health information. A letter of exemption was provided 
by the Nova Southeastern University IRB on May 28, 2016 (Appendix A). The tool 
focused on process, flow, continuity, specificity, accessibility, and reliability (ACOG, 
2012). The goal for the project was quality improvement of the process, and this goal was 
accomplished without the use of patient identifying information. Furthermore, the 
patients’ rights to privacy were protected under the Privacy Act of 1974 (U.S. 
Department of Justice, 2015). 
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Project Phases and Objectives 
 This project was implemented in five phases, some which overlapped or took 
place simultaneously. 
 Phase 1: Phase 1 began with an extensive literature review that provided evidence 
to support the imperativeness of utilizing an effective surveillance tool for cervical cancer 
screening (ACOG, 2012). During this phase, the gap in practice at the community center 
was identified and a request was made to develop a tool that tracked cervical cancer 
screening rates (CDC, 2014b). The request was made by the center’s medical director 
with the support of the risk manager. There were other stakeholders to consider and 
efforts were made to present the QI project in a positive manner and highlight the 
benefits of the initiative. 
 Phase 2: This was approval of the project. The facility agreement to conduct the 
project was finalized with two letters of approval on August 14, 2015 for the research, 
and on April 19, 2016 for cervical cancer surveillance only, and the work began on 
aligning the project goals with those of the stakeholders. The goals were to review the 
organization’s current process for surveillance, engage with staff to assess the needs they 
had identified regarding surveillance, and develop the tracking tool. Additionally, the 
facility’s annual QI survey that provided statistical data on preventive care for women 
had not been completed in over 2 years. Thus, the management supported the QI project. 
Staff were invited to participate through a flyer (Appendix B) distributed in 
patient care areas and posted in staff breakroom. Interested participants were sent a letter 
of participation explaining the study, their roles in participation, the risks and benefits, 
and confidentiality of their identities (Appendix C). This phase was ongoing, requiring 
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flexibility to adapt to the needs and requests of the organization. Good working 
relationships were also important in this phase, requiring collaboration for credible 
decisions regarding the proposed changes to a process that was familiar to most and did 
not require them to invest time and attention in learning a new system.  
 Phase 3: This phase was development of the screening tool. This phase consisted 
of gaining the approval of the course lead, mentor, and medical director for the 
community health center and making any final amendments prior to implementation. The 
phase also included presentation of a plan to orient staff to the new way of tracking 
cervical cytology. Introduction of the completed tool (Appendix D) during a designated 
time and place for training maximized the learning opportunity and decreased the risk of 
inadequate training due to competing priorities (Mira et al., 2012). 
 Phase 4: This phase included implementation and staff training on the revised 
protocol and surveillance tool. The phase incorporated steps to implement a tool that 
directed surveillance for cervical cancer screening. During this phase, the evidence was 
translated into practice. Some staff missed the initial training sessions, thus requiring one-
on-one or over-the-shoulder onsite training. However, it was anticipated that the majority 
of those involved would be prepared and equipped with the basic instructions to begin 
utilizing the tool.  
 Phase 5: In this phase, evaluation took place of staff interpretation of the 
surveillance tool effectiveness (Appendix E). Completion of the anonymous survey 
implied consent. The impact of the project on rates of screening and adherence to follow-
up could not be determined as part of this project. However, staff interpretation of 
effectiveness and efficiency compared to the previous program was evaluated. Putting the 
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plan into action should have decreased the likelihood that patients would be lost to 
follow-up. The plan-into-action should also have decreased the time staff spent on 
attempting to use a system that lacked standardization or efficiency. Success at this stage 
was staff evaluation that the tool improved efficiency and effectiveness of surveillance 
tracking for cervical cytology among age-appropriate women.   
Timeline 
 The timeline for this project was more dependent upon the host facility than 
originally anticipated. Initially, the timeline to completion was estimated at 24 weeks. 
Phase 1 was completed in 4 weeks. Phase 2 was completed in 9 weeks. Phase 2 called for 
development of a working tool that was revised and revamped to meet needs of the 
institution. Phases 3 and 4 required education and then practice; thus, allotted time for 
each was 5 weeks. The remaining 4 weeks were used to evaluate use and efficiency of the 
tool. To produce the best product possible, creation of a tool independent of stakeholder 
input would most likely have proved futile. Therefore, the timeline was reasonably 
adjusted throughout project development and implementation to accommodate 
participants’ necessary feedback. 
Resource Cost Analysis 
 The cost breakdown for this project was estimated at $2,683. The actual costs 
were significantly higher than the initial projection for expenditures. Upon calculating the 
budget, I underestimated travel, and access to the Internet was not included. The resource 
analysis is provided in Table 3.  
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 Table 3 
 
Itemized Cost Analysis for Project  
 
 
Resource 
 
Cost Projection  
 
 
Materials   
     Copy and Printing $100 
     Printer Paper and Cartridges $150 
     Name Badge $10 
     Lab Coats $50 
Technology  
     Portable Internet Access  $49/month $343 
Presentations for Tool Implementation  
     Refreshments $250 
Travel   
     Air Fare x 2 $400 
     POV x 8 average $110 round trip $880 
  
 
Total Estimated Expenditures 
 
            $2,183 
 
 
Outcome Measures 
 The goal of prevention instead of treatment prevails and was reiterated in Healthy 
People 2020 (2016a, 2016b) and the Affordable Care Act (United States Department of 
Labor, 2009). However, cervical cancer and STIs continue to be diagnosed at alarming 
rates (Centers for Disease Control and Prevention, 2014e). These statistics and personal 
contact with affected women daily in practice that spurred my efforts to seek measures to 
combat this disease burden. Sexually transmitted infections, which include HPV, cost the 
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American healthcare system nearly $16 billion each year (Centers for Disease Control 
and Prevention [CDC], 2013).  
As previously mentioned, the aim of this QI project was to address the gap in 
surveillance and tracking for cervical cancer. Five objectives were established that guided 
project planning, development, and implementation. The outcome measures are discussed 
below.  
 Objective 1. Address the gap in practice through application of an in-depth 
literature review to identify needs and deficiencies.  
 This objective was met by review of the literature and use of discovered evidence 
to substantiate the gap in practice and present support for the need of a standardized 
tracking system for clinical management of cervical cancer screening (Calhoun et al., 
2011; Fish et al., 2013; Stone et al., 2013). 
Objective 2. Promote the use of nationally recognized clinical practice 
recommendations when screening and making treatment decisions. 
This objective was quantified by establishment of relationships with facility 
stakeholders, implementation of a project to enhance the organization, and obtaining of 
support for project and IRB approval (Appendices A, B; ACOG, 2012a; Baraitser, 
Alexander, & Sheringham, 2011). Additionally, the Essentials of Doctoral Education for 
Advancing Nursing Practice VI. Interprofessional Collaboration for Improving Patient 
and Population Health Outcomes, and VII. Clinical Prevention and Population Health for 
Improving the Nation’s Health, were applicable and were utilized throughout project 
implementation (AACN, 2006).  
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 Objective 3. Develop protocol for screening, and institute electronic clinical 
reminder for the EMR to facilitate screening practices and documentation.  
This objective was adjusted dependent upon the facilities’ ability to make amendments to 
the EMR. The objective was met through collaboration with stakeholders, to include 
medical director and advanced registered nurse practitioner, and revamp of existing 
protocols where applicable to align facility practice with national clinical 
recommendations. The desired outcome was improved capture of healthcare needs. 
 Objective 4. Provide training on protocols, surveillance tool, and additions to 
EMR.  
 Training was ongoing, introduced during Phase 2, and fully implemented in Phase 
3. The goal was to provide training during a reserved time in a designated location that 
had limited distractions (Mira et al., 2012). An example was a lunch-and-learn, a 15- 
minute group session that allowed for staff attendance and time to complete other 
competing interests during their lunch break. Several sessions were required with varying 
presentations to illustrate the roles of the support staff comprised of the case manager and 
medical assistants. With a knowledgeable staff, patients will reap the benefits. The 
desired result for this objective was effective education and training that facilitated a 
smooth transition for the staff in using the new surveillance method. Consequently, user 
satisfaction and compliance with the tool provided the most valuable feedback for the 
objective. 
 Objective 5. Evaluate provider utilization and satisfaction with protocols and 
surveillance tool.  
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The final objective was accomplished during Phases 3-5 (Appendix E). 
Evaluation early in the process is important so that timely changes may be made to 
prevent major problems and dissatisfaction. This objective was met by a satisfaction 
survey for provider staff regarding satisfaction, use, and effectiveness of the policy 
changes and tool. Additional evaluation of utilization was accomplished through 
assessment of tool use, currency of data, and standardization in clinical practice. 
Summary 
 The literature indicates that the variance between clinical recommendations and 
actual practice has not been resolved. In response to the persisting epidemic of diseases 
that are largely preventable, such as cervical cancer, the roles of healthcare providers 
warrant further exploration (CDC, 2014a), especially in the day-to-day interactions with 
patients. The critical and central component to aid in meeting the objectives of this 
project is more screening. However, several studies noted provider practice as a 
significant contributor to missed opportunities to screen and treat HPV infection 
(Kettinger, 2013; Lanier et al., 2014; National Committee for Quality Assurance, 2011).  
It is true that patients may ignore warnings and medical advice. However, the 
need exists for consistent EBP among those charged with providing care. Whether 
patients knowingly or unknowingly put themselves at risk, they nevertheless deserve the 
best information and care that will result in the best outcomes for them. Improving 
surveillance is pivotal to the goal of optimizing outcomes. Leading with education, 
providers, staff, and patients are the stakeholders.  
An abundance of literature and references exist that may be applied to an 
ambulatory care setting. Resources and clinical recommendations are constantly 
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changing; keeping up with the vast number of changes is a difficult task. The patient’s 
role in prevention, detection, and treatment is critical as well but is an external factor for 
the initiative of a project such as the current one. Surveillance is an internal factor that 
may be controlled and is an important step towards affecting noticeable change for the 
disease burden of cervical cancer and the population most at risk. 
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Chapter 4 
Results and Discussion 
Cervical cancer is no longer the leading cause of cancer-related deaths for women 
in the United States and, according to the Centers for Disease Control and Prevention 
(CDC, 2016a), the decrease is attributable to the increase of women receiving regular 
testing via liquid-based cervical cytology screening and high-risk HPV testing. The 
potential also exists for an even greater decline in cervical cancer disease with the 
addition of the HPV vaccination. However, although the general health of the population 
has seen marked improvements, the outcomes for racial minorities continue to fall 
behind. Health disparities continue for African American women, and particularly those 
who are economically and educationally disadvantaged. Siegel, Ward, Brawley, and 
Jemal (2011) reported that potentially 37% of early cancer deaths could have been 
prevented 10 years ago if race and educational disparities did not exist.  
The collaboration of leading health organizations to develop guidelines for 
cervical cytology screening, follow-up, and treatment was an excellent initiative and 
provided standardization for care that was long awaited. However, the guidelines are only 
as useful as the individual provider’s interpretation and application in the clinical setting. 
With the widespread move for standardized care, much variation in practice remains 
(Darwish-Yassine et al., 2015). Subsequently, if variation exists in screening, the 
likelihood is high of variations during assessments of the process for tracking test results.  
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The literature indicates that the variance between clinical recommendations and actual 
practice has not been resolved (ACOG, 2012b; Darwish-Yassine et al., 2015; Fish et al., 
2013). In response to the persisting epidemic of diseases that are largely preventable, 
such as cervical cancer, the roles of healthcare providers warrant further exploration 
(CDC, 2014a), especially in the day-to-day interactions with patients. The critical and 
central component to aid in meeting the objectives of this project is more screening. 
However, several studies noted provider practice as a significant contributor to missed 
opportunities to screen and treat HPV infection (Kettinger, 2013; Lanier et al., 2014; 
National Committee for Quality Assurance, 2011).  
It is true that patients may ignore warnings and medical advice. However, the 
need exists for consistent EBP among those charged with providing care. Whether 
patients knowingly or unknowingly put themselves at risk, they nevertheless deserve the 
best information and care that will result in the best outcomes for them. Improving 
surveillance is pivotal to the goal of optimizing outcomes. Leading with education, 
providers, staff, and patients are the stakeholders.  
An abundance of literature and references exist that may be applied to an 
ambulatory care setting. Resources and clinical recommendations are constantly 
changing; keeping up with the vast number of changes is a difficult task. The patient’s 
role in prevention, detection, and treatment is critical as well but is an external factor for 
the initiative of a project such as the current one. Surveillance is an internal factor that 
may be controlled and is an important step towards affecting noticeable change for the 
disease burden of cervical cancer and the population most at risk.  
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Throughout the literature, there was a common theme of variation in screening 
practices, tracking, and innovative measures to improve follow-up once screening was 
completed (Calhoun, Goode, & Simmons, 2011; ACOG, 2012b; Fish et al., 2013). As a 
healthcare provider, I understand that a test is only effective if accompanied with 
intervention. That intervention may be additional testing, treatment, or simply patient 
education. Thus, a cervical cancer surveillance tool will only be effective if adequately 
implemented and applied to the clinical setting. To be efficient, the tool needs to be 
populated, maintained, and used appropriately to track patients to resolution. 
Results 
After a review of the needs of the community health center and specifically the 
women’s health department, at a meeting with the medical director and nurse practitioner 
in charge of the women’s clinic, the decision was made to develop a product that would 
enhance tracking of women who had Pap testing at the facility. The next meeting was 
held with the medical director and risk manager to approve project implementation for 
the tool at the site and grant permission to access the computer system. This permission 
led to facilitating integration of the tool into the department’s workflow once created and 
staff trained. Initial approval to conduct the QI initiative and subsequent approval to 
condense the initiative to cervical cancer surveillance only were provided. These 
approvals were followed by an exemption letter and approval to proceed with the study 
from the Nova Southeastern University IRB (Appendix A). 
Development of the project through evaluation took place in five phases, guided 
by the five objectives. The phases were as follows: (a) literature review, (b) project 
approval by site, (c) development of the surveillance tool, (d) tool implementation, and 
43 
 
 
 
(e) evaluation. The timeline established for phases included some overlap, and delays 
were experienced during Phases 4 and 5, implementation and evaluation, respectively.  
Implementation, which consisted of staff training, was often met with competing 
priorities.  
Staffing constraints, EMR upgrade, and two accreditation inspections were 
extenuating factors that impacted the timeline for full implementation. The final phase 
had to be modified to due to dependence upon in-house technology to load the tool onto 
the computer system. However, evaluation took place with participants using paper 
completion of the tool and not by electronic survey, as planned. Although the phases of 
intervention were adapted to meet the constraints of the organization, the objectives were 
met in accordance with the objective criteria.  
Objective 1: Address the gap in practice through application of an in-depth 
literature review to identify needs and deficiencies. 
 The first objective was met by completion of a thorough review of the literature 
and conducting of a needs assessment of the clinical site. The components of the 
literature search are described in Chapter 2. The literature clearly indicated that tracking 
of Pap test results was critical to preventive care for increasing early detection, which 
improved timely treatment.  
Additional support for substantiation of having met this objective was 
identification by stakeholders that the QI project would help the organization meet 
internal and external requirements for its annual QI survey. The survey that provided 
statistical data on preventive care for women had not been completed in over 2 years. 
Furthermore, the organization and the women’s health department desired to have an 
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improved method of capturing the Pap test results and follow-up for this patient 
population.  
Objective 2: Promote use of nationally recognized clinical practice 
recommendations when screening and making treatment decisions. 
 This objective and supporting criteria were also met. Clinical practice 
recommendations by ACOG, ASCCP, USPSTF, and ACS (Saslow et al., 2012) were 
shared with all women’s health staff, clinical leaders, and nursing supervisors. The 
guidelines for screening and algorithms for cytology as well as pathology were placed on 
a shared computer drive available to all clinical personnel. The wide distribution of 
guidelines was educational and increased accessibility for all interested personnel.  
With regard to screening practices, adherence to recommendations improved, and 
according to the supervising APRN, this improvement may have been attributed to the 
hiring of an obstetrician and gynecologist (OB/GYN) who helped manage workload and 
improved the staff’s ability to provide timely diagnostic testing. The nurse practitioner 
expressed concern that prior to the addition of the OB/GYN, the lack of services in-house 
may have contributed to a higher rate of loss to follow-up. Consequently, sustainment of 
this objective in the future is dependent upon staff and access to care. 
Objective 3: Develop protocol for screening, and institute electronic clinical 
reminder for the EMR to facilitate screening practices and documentation. 
 This objective was accomplished through modification of the objective, which 
was improved capture of healthcare needs. The protocol for screening had been last 
updated in 2014 and was reviewed with the ARNP who authored the protocol. After 
45 
 
 
 
review and revision, current clinical recommendations for cervical cancer screening and 
treatment were included. 
In addition, because of proprietary restrictions, changes could not be made to the 
EMR. However, training did take place on the existing reminders that were part of the 
EMR and were not being used. Orientation to existing features within the system was 
twofold: increased use of preventive care reminders that were universal across all clinics, 
and elimination of the need for creation and staff learning of a system that would be used 
by only one clinic. As previously stated, staffing was limited. Hence, improving usability 
of the existing system extended beyond one department but proved beneficial to the 
organization. 
Objective 4: Provide training on protocols, surveillance tools, and additions to 
EMR. 
 The outcome of this objective was evaluated by targeted staff members who 
received training on protocol, tracking tool, and embedded reminders within the EMR. 
The majority of training took place in an on-the-job manner. The original goal of group 
training did not take place because of time, staff conflicts, and competing priorities. Upon 
review, this method would not have been the best approach because staff did not have 
remote access to the computer system. Instead, one-on-one and over-the-shoulder training 
with no more than two staff allowed for more effective hands-on training, immediate 
answers to questions, and timely feedback regarding tool’s effectiveness. 
Objective 5: Evaluate provider utilization, satisfaction with protocols, and 
satisfaction with surveillance tool. 
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The final project objective was evaluated over several phases. During Phase 3, 
tool development, the importance of stakeholder input early in the process was 
recognized. The goal was to ensure that the needs of the organization were considered, as 
well as the usefulness and efficiency of the tool. Phase 4 implementation was also used as 
an evaluation period so that adjustments could be made prior to completion of the final 
product.  
The last phase and objective of the project outlined the evaluation process to be 
accomplished. According to the feedback provided from key staff and personnel, two of 
three components of the objective were met: satisfaction with protocols and satisfaction 
with development of surveillance tool. Provider utilization could not be evaluated due to 
limited access to the electronic tool prior to the end of evaluation period. However, 
providers did voice satisfaction and appreciation for the development of the tracking 
program and standardized surveillance tool that they perceived would increase their 
capacity to provide timely care to the organization’s female population.  
Expected and Unexpected Findings 
All phases of the project revealed expected and unexpected challenges and 
obstacles. Upon initial presentation of the proposal to conduct the study, the leadership 
accepted the project. The community health center is a nonprofit agency that operates on 
a restricted budget and depends heavily upon state and grant funding. Therefore, the 
opportunity to improve patient outcome in a manner that did not incur cost was appealing 
to and encouraged by the management. Further, the quality improvement project 
developed a method that did not previously exist to capture a specific population, filled a 
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void in patient care, and streamlined the staff workload. Direct and open-ended questions 
that were asked regarding tool indicated overall satisfaction with end product.  
The most unexpected findings were the degree of difficulty with gaining access to 
IT for support, loading the tool onto the computer system, and staffing constraints that 
limited personnel available to assume accountability for maintaining the tool. The 
assumption of ease of implementation of the project was made in error. The IT office 
department was staffed with one individual who served multiple locations. Therefore, the 
lack of additional personnel created a hardship with maintenance of scheduled meeting 
dates and times.  
Due to the IT staff member’s time and priority conflicts, an official request in 
writing, supported by the medical director, was made on June 1, 2016, for creation of a 
password- protected folder that could securely house the surveillance tool. With support 
of the medical director, I continued requests informally and formally. However, meeting 
these requests were delayed because of the IT staff member’s imperative duties: 
preparation for inspections, server upgrades, institution of new EMR, and various other 
concerns that received a higher priority than this project implementation. However, the 
APRN who supervised the women’s health department voiced satisfaction with the 
surveillance tool and assured me she was invested in ensuring the tool would be 
accessible electronically and implemented into the department’s daily operations. 
Strengths and Limitations 
A significant strength of the QI project was the ongoing support received from the 
stakeholders and staff. Two major limitations were the availability of IT support to fully 
implement project within the established time frame and inability to collect survey 
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responses. The only staff member who completed survey was a medical assistant. No 
licensed medical staff completed online survey that was requested through a link that was 
sent to their work email address. Additional strengths and limitations are outlined below 
in Table 4 with a Strength, Weakness, Opportunity, and Threat (SWOT) analysis.  
Implications for Nursing Practice, Outcome, Delivery, and Policy 
 
A review of the literature supported the finding that although cervical cancer has 
remained a leading cause of cancer-related death for women, when identified early and 
managed accordingly, mortality and morbidity are greatly reduced (Peirson, Fitzpatrick-
Lewis, Ciliska, & Warren, 2013). Despite barriers to care and documented health 
disparities, cervical cancer screening continues to be the single most effective preventive 
care screening for women of all ages, races, and socioeconomic backgrounds. The critical 
component in this modality of care is the timeliness of intervention, which often makes 
the difference between disease prevention and disease management.  
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Table 4  
SWOT Analysis of Project 
 
            Strengths 
 
            Weaknesses 
 
 
• Relationship building 
• Stakeholder involvement 
• Development of Pap tracking 
program 
• Decrease of loss to follow-up 
• Improvement of prioritization for 
patient appointments 
• Streamlined/standardized Pap 
surveillance 
• Improved capability for tracking to 
resolution 
• Improved capture of department 
workload 
• Provision of data required for 
organization quality and process 
improvement programs 
• Data tracking system to support 
need for contract OB/GYN 
 
 
• Limited personnel  
• Staff view tool as additional duty, 
increased workload 
• Resistance to delegating tool 
maintenance  
• Limited IT support 
• Lack of resources 
• Access to care demand exceeded 
access availability; staff reported 
time a factor in training/use of tool 
• Electronic tool not made available 
for full implementation, staff 
access 
 
 
             Opportunities 
             
           Threats 
 
 
• Good collaboration/support among 
stakeholders and key staff 
• Decreased loss to follow-up care 
• Decreased time from results to 
patient notification 
• Provide data for facility quality 
improvement and process 
improvement program evaluation 
• Standardized tracking program 
 
• Delayed process of tool 
availability 
• Staffing hours cut/potential to seek 
employment elsewhere 
• Limited access to IT (trouble-
shoot, address IT concerns) 
• Time  
• Limited personnel to sustain 
program 
• Limited resources 
• Resistance to change 
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The overarching goal of the QI initiative was to design a tool that would improve 
quality of care. The process incorporated actions that impacted the practice of care 
delivered, policy that drove practice, and ultimately patient outcome. The implications for 
practice are the promotion of interprofessional, quality, and evidence-based practice care. 
Modification of the cervical cancer surveillance process directly impacted nursing 
practice and delivery of care. Professional and unlicensed supportive nursing staff, 
comprised of APRN and medical assistants were responsible for management of the 
program, including coordination of care. The tracking tool was implemented as an 
electronic source, made available to all key personnel, and maintained in a centralized 
accessible location for pertinent clinical data relevant to cervical cancer screenings. This 
change in practice improved tracking and capture of patient with abnormal results, and 
increased opportunity to follow through until resolution of abnormal finding. 
Furthermore, institution of the tracking program incorporated evidence-based practice to 
standardize patient care activities and nursing staff workload.  
Relative to policy, the quality improvement project drove changes to local policy 
to support implementation of surveillance tool that not only centralized tracking, but also 
standardized tracking of Pap results. Prior to approval to conduct the study at the 
community health center, the Pap policy had last been revised in 2010. Cervical cancer 
screening for average-risk women was updated in 2012 and subsequently, areas of the 
policy were not aligned with the new clinical recommendations (CDC, 2012; USPSTF, 
2014). The project focus encouraged review of local policy and through collaboration 
with stakeholders, policy was updated and current clinical guidelines were made 
available to all involved staff. As a final point, through adherence to the changes made in 
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policy, access to written guidelines, and knowledge of team members’ individual roles, 
the optimal outcome of improved quality of care should be achieved. 
Future Research 
Cervical cancer screening has garnered global attention for many years. Various 
state, national, and worldwide organizations have conducted research and published 
information on the status of the disease. However, surveillance programs that are unique 
to cervical cancer have not yielded the same attention. Several studies within the 
literature review stressed the importance and need for tracking programs that would 
decrease the concern that accompanies low screening, which is inadequate follow-up 
(ACOG, 2012b; Stone et al., 2013).  
Markossian, Darnell, and Calhoun (2012) reported statistical data that low-
income, minority women faced significant barriers to care after abnormal Pap test results 
and were therefore less likely to receive timely treatment and intervention. Although 
several extenuating factors impacted timeliness to care, referral to higher levels of care 
was a top concern. If the appropriate level of care is not accomplished in a timely 
manner, disease progression could take place, another hurdle to overcome to ensure 
optimal patient outcomes.  
Additional research could be conducted replicating this study with larger 
populations and at other geographical locations. Results could be compared to the present 
ones for greater understanding of barriers to and resolutions of timely cervical cancer 
screening and follow-up. The screening methods of larger healthcare institutions could be 
studied as well for recommendations. 
52 
 
 
 
Additional quantitative studies could be conducted for satisfaction surveys of 
healthcare staff on use of a tool such as the present one. Studies with larger numbers of 
staff could help pinpoint deficiencies and enhance strengths of the tool. Revisions to the 
tool could increase staff use and timely detection. 
Qualitative studies could be conducted with staff involved in cervical cancer 
treatment (e.g., APRN, OB/GYN, clinic managers) for their responses to the efficacy of 
the tracking tool. Parallel studies could be conducted with patients who have benefited 
from the timely detection of cervical cancer and subsequent follow-up. As part of these 
studies, recommendations for improvement by each population could be requested.  
Research that focuses on tracking to resolution could improve health for women 
affected by mitigating the loss to follow-up and decreasing the time from diagnosis to 
management.  
Summary 
Healthy People 2020 (2016a, 2016b) selected cancer as one of its primary topics 
and objectives with a goal to decrease the number of new cases and associated 
complications on diagnosis. In addition to colorectal and breast cancer, the objective 
specifically targeted cervical cancer and called for support of efforts to reduce the 
cervical cancer disease burden in the United States. The prevalence of cervical cancer and 
the global initiative for preventive care, cancer risk reduction, and disease management 
reinforce the importance of results tracking.  
Women’s health care physicians governed by ACOG reaffirmed their opinion of 
results tracking that stated “practices should establish reliable tracking and reminding 
systems that improve patient safety, quality of care, and minimize delay in care” (ACOG, 
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2012b, p. 1). Although useful, a results tracking system is not intended to be a substitute 
for patient accountability and responsibility for their individual health. However, when 
properly utilized, a cervical cancer surveillance program is an effective method for 
helping patients receive the appropriate care, within the appropriate time frame, to 
achieve optimal health outcomes.  
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Appendix A 
Nova Southeastern University IRB Exemption Letter 
 
MEMORANDUM 
 
To:  NaQuita J Manning, MSN 
  College of Nursing 
 
From:  Jo Ann Kleier, Ph.D., Ed.D.   
  Center Representative, Institutional Review Board 
  
Date:  May 28, 2016 
 
Re: IRB #:  2016-205; Title, “EVALUATION OF A CERVICAL 
CANCER SURVEILLANCE PROGRAM AT A COMMUNITY 
HEALTH CENTER” 
 
I have reviewed the above-referenced research protocol at the center level. Based on the 
information provided, I have determined that this study is exempt from further IRB 
review under 45 CFR 46.101(b) (Exempt Category 2). You may proceed with your 
study as described to the IRB. As principal investigator, you must adhere to the following 
requirements: 
 
1) CONSENT:  If recruitment procedures include consent forms, they must be 
obtained in such a manner that they are clearly understood by the subjects and the 
process affords subjects the opportunity to ask questions, obtain detailed answers 
from those directly involved in the research, and have sufficient time to consider 
their participation after they have been provided this information. The subjects 
must be given a copy of the signed consent document, and a copy must be placed 
in a secure file separate from de-identified participant information. Record of 
informed consent must be retained for a minimum of three years from the 
conclusion of the study. 
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2) ADVERSE EVENTS/UNANTICIPATED PROBLEMS:  The principal 
investigator is required to notify the IRB chair and me (954-262-5369 and Jo Ann 
Kleier, Ph.D., Ed.D., respectively) of any adverse reactions or unanticipated events 
that may develop as a result of this study. Reactions or events may include, but are 
not limited to, injury, depression as a result of participation in the study, life-
threatening situation, death, or loss of confidentiality/anonymity of subject. Approval 
may be withdrawn if the problem is serious. 
3) AMENDMENTS:  Any changes in the study (e.g., procedures, number or types of 
subjects, consent forms, investigators, etc.) must be approved by the IRB prior to 
implementation. Please be advised that changes in a study may require further review 
depending on the nature of the change. Please contact me with any questions 
regarding amendments or changes to your study. 
The NSU IRB is in compliance with the requirements for the protection of human 
subjects prescribed in Part 46 of Title 45 of the Code of Federal Regulations (45 CFR 46) 
revised June 18, 1991. 
 
Cc: Eglintine Rigaud, Ph.D.  
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Appendix B 
 
Flyer 
 
      Cervical Cancer Surveillance 
 
 
Cervical Cancer Surveillance 
 
 
 
 
 
 
 
 
 
 
Presented by: 
NaQuita J. Manning, MSN, WHNP-BC  
Doctor of Nursing Practice Student 
 
Significance of the Problem 
 
Cervical cancer is the easiest gynecologic cancer to prevent, 
achievable through regular screening and timely follow-up 
(CDC, 2014). . . When detected at an early stage, women 
who develop invasive cervical cancer have a 5-year survival 
rate of 91% (American Cancer Society, 2015). . .  
 
U.S. Preventive Services Task Force, American College of 
Obstetricians and Gynecologists, American Cancer Society, 
and American Society for Colposcopy and Cervical 
Pathology concur on the methodology for cervical cancer 
screening for average-risk women. 
 
        
   
Implications for Practice 
•Improve cervical cancer surveillance  
 
•Healthcare Outcomes- increase in age appropriate cervical 
cancer screenings, increase in ratio of number of patients 
screened for number of patient encounters, and timely follow-
up care;  early detection, early intervention, and prevention. 
 
•Success equals improved healthcare outcomes 
 
Quality Improvement Initiative 
   The purpose is to develop a tracking tool for Cervical Cytology to enhance 
surveillance measures 
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Appendix C 
 
Participation Letter  
 
Title of Study: Evaluation of a Cervical Cancer Surveillance Program at a Community 
Health Center 
 
Principal investigator     Co-investigator 
NaQuita J. Manning, MSN    Eglintine Rigaud, PhD 
 
Institutional Review Board    Site Information  
Nova Southeastern University    Community Health Center 
Office of Grants and Contracts     
(954) 262-5369/Toll Free: 866-499-0790   
IRB@nsu.nova.edu      
 
Description of Study: NaQuita Manning is a doctoral student at Nova Southeastern 
University engaged in a clinical capstone project for the purpose of satisfying a 
requirement for a Doctor of Nursing Practice degree. This quality improvement (QI) 
project involved the assessment of the cervical cancer surveillance program at a 
community health center that provides care to women of varied age, race, and economic 
backgrounds. The purpose of this QI project is to develop an evidence-based, updated 
tracking tool for cervical cytology screening to facilitate surveillance measures in a CHC, 
contributing to early detection, timely treatment, decrease cost burden associated delay in 
care, and optimally healthier patient outcomes.  
 
If you agree to participate, you will be asked to complete the attached questionnaire. This 
questionnaire will help the writer identify the strengths and weakness of the developed 
cervical cancer tracking tool. The data from this questionnaire will be used to identify the 
needs of the healthcare providers that use the tool in order to meet the needs of cervical 
cancer surveillance program. The questionnaire will take approximately five minutes to 
complete.  
Risks/Benefits to the Participant: There may be minimal risk involved in participating 
in this study. There are no direct benefits to for agreeing to be in this study. Please 
understand that although you may not benefit directly from participation in this study, 
you have the opportunity to enhance knowledge necessary to develop a usable cervical 
cancer tracking tool within your institution. If you have any concerns about the 
risks/benefits of participating in this study, you can contact the investigators and/or the 
university’s human research oversight board (the Institutional Review Board or IRB) at 
the numbers listed above.  
 
Cost and Payments to the Participant: There is no cost for participation in this 
study. Participation is completely voluntary and no payment will be provided.  
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Confidentiality: Information obtained in this study is strictly confidential unless 
disclosure is required by law. All data will be secured in a locked filing cabinet. Your 
name will not be used in the reporting of information in publications or conference 
presentations.  
Participant’s Right to Withdraw from the Study: You have the right to refuse to 
participate in this study and the right to withdraw from the study at any time without 
penalty.  
I have read this letter and I fully understand the contents of this document 
and voluntarily consent to participate. All of my questions concerning this 
research have been answered. If I have any questions in the future about this 
study they will be answered by the investigator listed above or his/her staff.  
 
I understand that the completion of this questionnaire implies my consent to 
participate in this study.  
66 
 
 
 
Appendix D 
Cervical Cancer Surveillance Tool  
Patient Information 
       
 
Pap Test 
Information 
 
            Follow-up Information 
   
Patient Name 
 
Age 
 
Medical 
Record # 
 
Provider 
 
Date 
of Pap 
 
Pap 
Results 
 
Date Pt 
Contacted 
/Staff 
Initials 
 
Date 
of F/U 
GYN 
Appt 
 
Status of 
F/U 
(Kept/Canc
elled/No-
Show) 
 
Notes:. (No 
Show, 
Rescheduled,
, Letter 
mailed, 
Referred, 
Resolved) 
 
                    
                    
                    
                    
                    
                    
                    
                    
                    
      
Note: Staff contacting patients will place initials next to date.
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Appendix E 
 
Cervical Cancer Surveillance Tool 
Satisfaction Survey 
 
1. How would you rate the ease of access to the cervical cancer surveillance/pap smear 
tracking tool? 
o Very Easy 
o Easy 
o Neutral 
o Difficult 
o Very Difficult 
 
2. How would you rate orientation use of the surveillance tool? 
o Very Good 
o Good 
o Fair 
o Poor 
o Very Poor 
 
3. How would you rate the usefulness of the tool for your clinical environment? 
o Very Good 
o Good 
o Fair  
o Poor 
o Very Poor 
 
4. How would you rate the effectiveness of the tool in meeting your needs as member of 
the healthcare provider team? 
o Very Good 
o Good 
o Fair 
o Poor 
o Very Poor 
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5. How would you rate the information provided within the tool? 
o Too much information 
o The right amount of information 
o Too little information 
o The wrong information 
 
6. How would you rate your overall satisfaction with the cervical cancer surveillance/pap 
smear tracking tool? 
o Very Satisfied 
o Satisfied 
o Neutral 
o Dissatisfied 
o Very Dissatisfied 
 
7. Comments 
 
 
 
 
 
 
 
 
 
 
